Prospective Study Finds Potential Utility of MeMed’s Host Immune Technology for Personalizing Treatment of Severe COVID-19 Patients

NEXT STORY
BrainStorm Announces Groundbreaking Pre-Clinical Study of NurOwn® derived Exosome-Based Treatment for COVID-19 ARDS
PREV STORY
First half of the year with 1%1 growth at constant exchange rates, significant impact of COVID-19 pandemic
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Telemedicine and Home Care

The telemedicine visits also helped providers identify ways to improve the neonatal ICU (NICU) ...

author_avatar
services

Healthcare Watch

TeleMed Text: Majority of Patients Find Health Info on Internet Doctors may be unaware ...

PM360 Staff
PM360 Staff

Can Mobile Solve a $289 Billion Problem?

In a mobile world, providing seamless content delivery and an elegant user experience is ...

Sam Welch
Sam Welch